MedTrace Logo

IASTM Effects on Pain, Functionality, and Proprioception in Subacromial Impingement

NCT07293702 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2026-03-25

No results posted yet for this study

Summary

The aim of this study will be to investigate the effects of Instrument-Assisted Soft Tissue Mobilization (IASTM), applied in addition to a conventional exercise program, on pain, range of motion, proprioception, functionality, and quality of life in individuals with Subacromial Impingement Syndrome (SIS).

Conditions

  • Subacromial Impingement Syndrome
  • Massage
  • Instrument-Assisted Soft Tissue Mobilization
  • Soft Tissue Injuries

Interventions

OTHER

Conventional exercise group

All participants will receive a standardized electrotherapy program in a clinical setting, consisting of TENS (100 Hz, 30 minutes), ultrasound (1.5 W/cm², 8 minutes), and a 15-minute cold-pack application, delivered three times per week for four weeks. In addition to electrotherapy, participants in the conventional exercise group will perform a physiotherapist-guided exercise program aimed at improving shoulder flexion, abduction, internal and external rotation through stretching and range-of-motion exercises. The program will include Codman exercises, wand exercises, finger-ladder activities, and condition-appropriate strengthening exercises, progressed according to each participant's pain level and tolerance.

OTHER

IASTM group

Participants in the IASTM group will receive Instrument-Assisted Soft Tissue Mobilization in addition to the conventional treatment program, three days per week for four weeks, for a total of 12 sessions. The IASTM technique will be applied to the subscapularis, anterior deltoid, biceps brachii, upper trapezius, supraspinatus, infraspinatus, teres major, teres minor, and posterior deltoid muscles. For each muscle group, the treatment will be administered for 20 seconds in a parallel direction and 20 seconds in a perpendicular direction, using sweep and brush techniques at an angle of approximately 45 degrees.

Sponsors & Collaborators

  • Istanbul Medipol University Hospital

    lead OTHER

Principal Investigators

  • Burak Menek, PhD · Medipol University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-25
Primary Completion
2026-05-10
Completion
2026-05-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07293702 on ClinicalTrials.gov